These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 20652684)

  • 1. Intravenous colistimethate administration and colistin lung tissue concentrations.
    Imberti R
    Intensive Care Med; 2010 Oct; 36(10):1795. PubMed ID: 20652684
    [No Abstract]   [Full Text] [Related]  

  • 2. Uptake of higher intravenous colistin methanesulfonate dosing in hospitals in the Gulf Cooperation Council states. A Web-based survey study.
    Omrani AS; Alfahad WA; Albarrak AM
    Saudi Med J; 2013 Nov; 34(11):1195-6. PubMed ID: 24252901
    [No Abstract]   [Full Text] [Related]  

  • 3. Pulmonary and systemic pharmacokinetics of inhaled and intravenous colistin methanesulfonate in cystic fibrosis patients: targeting advantage of inhalational administration.
    Yapa SWS; Li J; Patel K; Wilson JW; Dooley MJ; George J; Clark D; Poole S; Williams E; Porter CJ; Nation RL; McIntosh MP
    Antimicrob Agents Chemother; 2014 May; 58(5):2570-9. PubMed ID: 24550334
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimization of colistin dosing regimen for cystic fibrosis patients with chronic Pseudomonas aeruginosa biofilm lung infections.
    Hengzhuang W; Green K; Pressler T; Skov M; Katzenstein TL; Wu X; Høiby N
    Pediatr Pulmonol; 2019 May; 54(5):575-580. PubMed ID: 30803159
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Urinary Concentrations of Colistimethate and Formed Colistin after Intravenous Administration in Patients with Multidrug-Resistant Gram-Negative Bacterial Infections.
    Luque S; Escaño C; Sorli L; Li J; Campillo N; Horcajada JP; Salas E; Grau S
    Antimicrob Agents Chemother; 2017 Aug; 61(8):. PubMed ID: 28559275
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Colistin Population Pharmacokinetics after Application of a Loading Dose of 9 MU Colistin Methanesulfonate in Critically Ill Patients.
    Karaiskos I; Friberg LE; Pontikis K; Ioannidis K; Tsagkari V; Galani L; Kostakou E; Baziaka F; Paskalis C; Koutsoukou A; Giamarellou H
    Antimicrob Agents Chemother; 2015 Dec; 59(12):7240-8. PubMed ID: 26369974
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of Colistin Following a Single Dose of Intravenous Colistimethate Sodium in Critically Ill Neonates.
    Nakwan N; Usaha S; Chokephaibulkit K; Villani P; Regazzi M; Imberti R
    Pediatr Infect Dis J; 2016 Nov; 35(11):1211-1214. PubMed ID: 27276179
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Population WB-PBPK Model of Colistin and its Prodrug CMS in Pigs: Focus on the Renal Distribution and Excretion.
    Viel A; Henri J; Bouchène S; Laroche J; Rolland JG; Manceau J; Laurentie M; Couet W; Grégoire N
    Pharm Res; 2018 Mar; 35(5):92. PubMed ID: 29532176
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics of colistin in critically ill patients with multidrug-resistant Gram-negative bacilli infection.
    Karnik ND; Sridharan K; Jadhav SP; Kadam PP; Naidu RK; Namjoshi RD; Gupta V; Gore MS; Surase PV; Mehta PR; Gogtay JA; Thatte UM; Gogtay NJ
    Eur J Clin Pharmacol; 2013 Jul; 69(7):1429-36. PubMed ID: 23508665
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Colistin penetration in the alveolar lining fluid of critically ill patients treated with IV colistimethate sodium.
    Markou N; Fousteri M; Markantonis SL; Boutzouka E; Tsigou E; Baltopoulo G
    Chest; 2011 Jan; 139(1):232-3; author reply 233-4. PubMed ID: 21208892
    [No Abstract]   [Full Text] [Related]  

  • 11. Population Pharmacokinetics of Intravenous Colistin in Pediatric Patients: Implications for the Selection of Dosage Regimens.
    Ooi MH; Ngu SJ; Chor YK; Li J; Landersdorfer CB; Nation RL
    Clin Infect Dis; 2019 Nov; 69(11):1962-1968. PubMed ID: 30722017
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics of four different brands of colistimethate and formed colistin in rats.
    He H; Li JC; Nation RL; Jacob J; Chen G; Lee HJ; Tsuji BT; Thompson PE; Roberts K; Velkov T; Li J
    J Antimicrob Chemother; 2013 Oct; 68(10):2311-7. PubMed ID: 23749953
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intravenous colistin administration in neonates.
    Jajoo M; Kumar V; Jain M; Kumari S; Manchanda V
    Pediatr Infect Dis J; 2011 Mar; 30(3):218-21. PubMed ID: 21245777
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systemic pharmacokinetics and safety of high doses of nebulized colistimethate sodium in critically ill patients with hospital-acquired and ventilator-associated pneumonia.
    Benítez-Cano A; de Antonio-Cuscó M; Luque S; Sorlí L; Carazo J; Ramos I; Bermejo S; Campillo N; Horcajada JP; Samsó E; Grau S
    J Antimicrob Chemother; 2019 Nov; 74(11):3268-3273. PubMed ID: 31495877
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pulmonary and Systemic Pharmacokinetics of Colistin Following a Single Dose of Nebulized Colistimethate in Mechanically Ventilated Neonates.
    Nakwan N; Lertpichaluk P; Chokephaibulkit K; Villani P; Regazzi M; Imberti R
    Pediatr Infect Dis J; 2015 Sep; 34(9):961-3. PubMed ID: 26065861
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical efficacy and pharmacokinetics of colistimethate sodium and colistin in critically ill patients in an Indian hospital with high endemic rates of multidrug-resistant Gram-negative bacterial infections: A prospective observational study.
    Moni M; Sudhir AS; Dipu TS; Mohamed Z; Prabhu BP; Edathadathil F; Balachandran S; Singh SK; Prasanna P; Menon VP; Patel T; Patel P; Kaye KS; Menon VP
    Int J Infect Dis; 2020 Nov; 100():497-506. PubMed ID: 32781161
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Changes in the dosing of colistimethate sodium in critically ill patients].
    Ortega-García MP; Abril-López de Medrano V; Gimeno-Cardona C
    Rev Esp Quimioter; 2016 Feb; 29(1):53-4. PubMed ID: 26785228
    [No Abstract]   [Full Text] [Related]  

  • 18. Steady-state pharmacokinetics of intravenous colistin methanesulphonate in patients with cystic fibrosis.
    Li J; Coulthard K; Milne R; Nation RL; Conway S; Peckham D; Etherington C; Turnidge J
    J Antimicrob Chemother; 2003 Dec; 52(6):987-92. PubMed ID: 14585859
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Substantial Targeting Advantage Achieved by Pulmonary Administration of Colistin Methanesulfonate in a Large-Animal Model.
    Landersdorfer CB; Nguyen TH; Lieu LT; Nguyen G; Bischof RJ; Meeusen EN; Li J; Nation RL; McIntosh MP
    Antimicrob Agents Chemother; 2017 Jan; 61(1):. PubMed ID: 27821445
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Colistimethate sodium dry powder for inhalation: a review of its use in the treatment of chronic Pseudomonas aeruginosa infection in patients with cystic fibrosis.
    Conole D; Keating GM
    Drugs; 2014 Mar; 74(3):377-87. PubMed ID: 24510624
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.